Correlation between risk factors for vascular disease and the American Urological Association Symptom Score

被引:21
作者
Gibbons, Erin P. [1 ]
Colen, John [1 ]
Nelson, Joel B. [1 ]
Benoit, Ronald M. [1 ]
机构
[1] Univ Pittsburgh, Dept Urol, Pittsburgh, PA USA
关键词
AUA symptom score; vascular disease; LUTS;
D O I
10.1111/j.1464-410X.2007.06548.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To evaluate the correlation between risk factors for vascular disease and the American Urological Association Symptom Score (AUA-SS), by comparing the presence of these risk factors with the degree of lower urinary tract symptoms (LUTS). PATIENTS AND METHODS We retrospectively reviewed the medical history, AUA-SS, and prostate volume of men who had a radical prostatectomy. The degree of LUTS in men with and without risk factors for cardiovascular disease was compared. RESULTS The mean AUA-SS was 7.2 for the entire cohort, 5.6 in men with no risk factors, and 7.9 in men with at least one risk factor (P < 0.05). In men with one to four risk factors, the mean AUA-SS was 6.9, 7.9, 10.7, and 19.5, respectively. There was no correlation between the AUA-SS and prostate size in the entire cohort or among any groups. CONCLUSIONS Men with risk factors for vascular disease are more likely to have a higher AUA-SS than men without these risk factors. These findings suggest the possibility of an association between vascular disease and the development and severity of LUTS in men.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 24 条
  • [1] RELATIONSHIP OF SYMPTOMS OF PROSTATISM TO COMMONLY USED PHYSIOLOGICAL AND ANATOMICAL MEASURES OF THE SEVERITY OF BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    COCKETT, ATK
    HOLTGREWE, HL
    MCCONNELL, JD
    SIHELNIK, SA
    WINFIELD, HN
    [J]. JOURNAL OF UROLOGY, 1993, 150 (02) : 351 - 358
  • [2] Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction
    Berger, AP
    Deibl, M
    Leonhartsberger, N
    Bektic, J
    Horninger, W
    Fritsche, G
    Steiner, H
    Pelzer, AE
    Bartsch, G
    Frauscher, F
    [J]. BJU INTERNATIONAL, 2005, 96 (07) : 1073 - 1078
  • [3] Bloch W, 1997, PROSTATE, V33, P1
  • [4] Bourke J B, 1966, Br J Urol, V38, P18, DOI 10.1111/j.1464-410X.1966.tb09675.x
  • [5] NITRIC-OXIDE CONTROL OF LOWER GENITOURINARY TRACT FUNCTIONS - A REVIEW
    BURNETT, AL
    [J]. UROLOGY, 1995, 45 (06) : 1071 - 1083
  • [6] Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy
    Hahn, RG
    Farahmand, BY
    Kallin, A
    Hammar, N
    Persson, PG
    [J]. UROLOGY, 2000, 55 (02) : 236 - 240
  • [7] Hamilton W, 2004, BRIT J GEN PRACT, V54, P617
  • [8] HOPPS CV, 2003, J UROLOGY, V1689, pA4101
  • [9] Natural history of benign prostatic hyperplasia
    Jacobsen, SJ
    Girman, CJ
    Lieber, MM
    [J]. UROLOGY, 2001, 58 (6A) : 5 - 16
  • [10] Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia
    Klotz T.
    Mathers M.J.
    Bloch W.
    Nayal W.
    Engelmann U.
    [J]. International Urology and Nephrology, 1999, 31 (3) : 335 - 341